Cargando…
Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?
Strategies targeting intracellular negative regulators such as immune checkpoint inhibitors (ICPIs) have demonstrated significant antitumor activity across a wide range of solid tumors. In the clinical practice, the radiological effect of immunotherapeutic agents has raised several more relevant and...
Autores principales: | Bauckneht, Matteo, Piva, Roberta, Sambuceti, Gianmario, Grossi, Francesco, Morbelli, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Co., Limited
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334499/ https://www.ncbi.nlm.nih.gov/pubmed/28298962 http://dx.doi.org/10.4329/wjr.v9.i2.27 |
Ejemplares similares
-
Contrast-enhanced [(18) F] fluorodeoxyglucose-positron emission tomography/computed tomography in clinical oncology: tumor-, site-, and question-based comparison with standard positron emission tomography/computed tomography
por: Morbelli, Silvia, et al.
Publicado: (2014) -
18F-Fluorodeoxyglucose Positron Emission Tomography Tracks the Heterogeneous Brain Susceptibility to the Hyperglycemia-Related Redox Stress
por: Miceli, Alberto, et al.
Publicado: (2020) -
Positron Emission Tomography-Based Response to Target and Immunotherapies in Oncology
por: Donegani, Maria Isabella, et al.
Publicado: (2020) -
Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence
por: Piva, Roberta, et al.
Publicado: (2017) -
Positron Emission Tomography (PET) Imaging of Multiple Myeloma in a Post-Treatment Setting
por: Ferrarazzo, Giulia, et al.
Publicado: (2021)